Børresen-Dale AL - Search Results

1

Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.

Murph MM, Liu W, Yu S, Lu Y, Hall H, Hennessy BT, Lahad J, Schaner M, Helland A, Kristensen G, Børresen-Dale AL, Mills GB. Murph MM, et al. PLoS One. 2009;4(5):e5583. doi: 10.1371/journal.pone.0005583. Epub 2009 May 15. PLoS One. 2009. PMID: 19440550 Free PMC article.

2

Microsatellite instability in cervical and endometrial carcinomas.

Helland A, Børresen-Dale AL, Peltomäki P, Hektoen M, Kristensen GB, Nesland JM, de la Chapelle A, Lothe RA. Helland A, et al. Int J Cancer. 1997 Mar 4;70(5):499-501. doi: 10.1002/(sici)1097-0215(19970304)70:5<499::aid-ijc1>3.0.co;2-t. Int J Cancer. 1997. PMID: 9052745 Free article.

3

Allelic imbalance at chromosome region 11q23 in cervical carcinomas.

Skomedal H, Helland A, Kristensen GB, Holm R, Børresen-Dale AL. Skomedal H, et al. Eur J Cancer. 1999 Apr;35(4):659-63. doi: 10.1016/s0959-8049(98)00413-4. Eur J Cancer. 1999. PMID: 10492643

4

p53 polymorphism and cervical cancer.

Helland A, Børresen-Dale AL. Helland A, et al. Lancet. 1999 Oct 30;354(9189):1561-2. doi: 10.1016/S0140-6736(05)76596-X. Lancet. 1999. PMID: 10551531 No abstract available.

5

Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: evaluation of allelic imbalance at FHIT, RB1 and TP53 in relation to survival.

Helland A, Kraggerud SM, Kristensen GB, Holm R, Abeler VM, Huebner K, Borresen-Dale AL, Lothe RA. Helland A, et al. Int J Cancer. 2000 Oct 15;88(2):217-22. doi: 10.1002/1097-0215(20001015)88:2<217::aid-ijc11>3.0.co;2-i. Int J Cancer. 2000. PMID: 11004671 Free article.

6

Fibroblast growth factor receptor 3 (FGFR3) - analyses of the S249C mutation and protein expression in primary cervical carcinomas.

Dai H, Holm R, Kristensen GB, Abeler VM, Børresen-Dale AL, Helland A. Dai H, et al. Anal Cell Pathol. 2001;23(2):45-9. doi: 10.1155/2001/521873. Anal Cell Pathol. 2001. PMID: 11904459 Free PMC article.

7

Gene expression patterns in ovarian carcinomas.

Schaner ME, Ross DT, Ciaravino G, Sorlie T, Troyanskaya O, Diehn M, Wang YC, Duran GE, Sikic TL, Caldeira S, Skomedal H, Tu IP, Hernandez-Boussard T, Johnson SW, O'Dwyer PJ, Fero MJ, Kristensen GB, Borresen-Dale AL, Hastie T, Tibshirani R, van de Rijn M, Teng NN, Longacre TA, Botstein D, Brown PO, Sikic BI. Schaner ME, et al. Mol Biol Cell. 2003 Nov;14(11):4376-86. doi: 10.1091/mbc.e03-05-0279. Epub 2003 Sep 5. Mol Biol Cell. 2003. PMID: 12960427 Free PMC article.

8

X chromosome inactivation in cervical cancer patients.

Kristiansen M, Helland A, Kristensen GB, Olsen AO, Lønning PE, Børresen-Dale AL, Ørstavik KH. Kristiansen M, et al. Cancer Genet Cytogenet. 2003 Oct 1;146(1):73-6. doi: 10.1016/s0165-4608(03)00152-3. Cancer Genet Cytogenet. 2003. PMID: 14499700

9

Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma.

Wang Y, Kringen P, Kristensen GB, Holm R, Baekelandt MM, Olivier M, Skomedal H, Hainaut P, Tropé CG, Abeler VM, Nesland JM, Børresen-Dale AL, Helland A. Wang Y, et al. Hum Mutat. 2004 Jul;24(1):21-34. doi: 10.1002/humu.20055. Hum Mutat. 2004. PMID: 15221786

10

High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas.

Benetkiewicz M, Wang Y, Schaner M, Wang P, Mantripragada KK, Buckley PG, Kristensen G, Børresen-Dale AL, Dumanski JP. Benetkiewicz M, et al. Genes Chromosomes Cancer. 2005 Mar;42(3):228-37. doi: 10.1002/gcc.20128. Genes Chromosomes Cancer. 2005. PMID: 15578687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

508 results

Search Page